Bacopa Monnieri

Last Updated: September 28 2022

Bacopa monnieri is a nootropic herb that has been used in traditional medicine for longevity and cognitive enhancement. Supplementation can improve memory, at least in the short-term, and there may be some mental health benefits.

Bacopa Monnieri is most often used for

What is Bacopa monnieri?

Bacopa monnieri, commonly known as water hyssop, is an herb often used in Ayurveda. It is taken for the purpose of improving cognitive function, stress relief, and a general enhancement of vitality. Bacopa monnieri interacts with the dopamine and serotonin systems, but its main mechanism concerns promoting neuron communication. It does this by increasing the growth of dendrites. Bacopa monnieri also has antioxidant effects.

What are Bacopa monnieri's benefits?

An improvement in memory is the only known benefit of Bacopa, and the effect tends to be inconsistent across different tests and scenarios, making it difficult to know specifically when it’s beneficial. Though effects of this nature are usually studied in the elderly, Bacopa monnieri appears to affect young people as well. Some preliminary research suggests that it can reduce cortisol secretion and the depletion of dopamine and serotonin during chronic stress, but more research is needed to confirm this. It may have antidepressant effects, but is largely unproven for that purpose.

What are Bacopa monnieri's side effects and drawbacks?

Taking Bacopa monnieri on an empty stomach may cause nausea, cramping, bloating, and diarrhea. Since Bacopa monnieri may have anxiolytic (anxiety reducing) effects, a relaxed person might experience a lack of motivation to work after supplementation, and it may not be safe to take it in conjunction with other anxiolytics.

What else is Bacopa Monnieri known as?
Note that Bacopa Monnieri is also known as:
  • Brahmi
  • Aindri
  • Lysimachia Monnieri L. Cent.
  • Graticola Monnieri L.
  • Herpestis Monniera L. Kunth.
  • Water Hyssop
  • Thyme-leafed Gratiola
  • Indian Pennywort
  • Jalabrahmi
Bacopa Monnieri should not be confused with:
Dosage information

The standard dose for Bacopa monnieri is 300mg, assuming that the total bacoside content (the active compound) is 55% of the extract, by weight. Higher doses haven't been consistently shown to lead to greater effects.

Bacopa monnieri can also be supplemented in a leaf or powder form. To achieve the ideal 10-20% of bacoside content requires a dose of 750-1,500mg of the leaf or powder.

Historically, Bacopa monnieri was consumed with ghee, a clarified butter that originated in India. Since Bacopa monnieri is fat soluble and requires a lipoid transporter to be absorbed, it should be supplemented alongside a meal.

Supplements Demystified: Get Our Unbiased, Evidence-Based Guide

Examine Database: Bacopa Monnieri
What works and what doesn't?

Unlock the full potential of Examine

Get started

Don't miss out on the latest research

References
2.^Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande MScientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandhaCent Nerv Syst Agents Med Chem.(2010 Sep 1)
3.^Shinomol GK, Muralidhara, Bharath MMExploring the role of "Brahmi" (Bocopa monnieri and Centella asiatica) in brain function and therapyRecent Pat Endocr Metab Immune Drug Discov.(2011 Jan)
4.^Singh RH, Narsimhamurthy K, Singh GNeuronutrient impact of Ayurvedic Rasayana therapy in brain agingBiogerontology.(2008 Dec)
5.^Mukherjee S, Dugad S, Bhandare R, Pawar N, Jagtap S, Pawar PK, Kulkarni OEvaluation of comparative free-radical quenching potential of Brahmi (Bacopa monnieri) and Mandookparni (Centella asiatica)Ayu.(2011 Apr)
6.^Russo A, Borrelli FBacopa monniera, a reputed nootropic plant: an overviewPhytomedicine.(2005 Apr)
9.^Bhandari P, Kumar N, Singh B, Kaul VKBacosterol glycoside, a new 13,14-seco-steroid glycoside from Bacopa monnieriChem Pharm Bull (Tokyo).(2006 Feb)
13.^Deb DD, Kapoor P, Dighe RP, Padmaja R, Anand MS, D'Souza P, Deepak M, Murali B, Agarwal AIn vitro safety evaluation and anticlastogenic effect of BacoMind on human lymphocytesBiomed Environ Sci.(2008 Feb)
14.^Murthy PB, Raju VR, Ramakrisana T, Chakravarthy MS, Kumar KV, Kannababu S, Subbaraju GVEstimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatographyChem Pharm Bull (Tokyo).(2006 Jun)
17.^Deepak M, Sangli GK, Arun PC, Amit AQuantitative determination of the major saponin mixture bacoside A in Bacopa monnieri by HPLCPhytochem Anal.(2005 Jan-Feb)
18.^Phrompittayarat W, Wittaya-areekul S, Jetiyanon K, Putalun W, Tanaka H, Ingkaninan KStability studies of saponins in Bacopa monnieri dried ethanolic extractsPlanta Med.(2008 Nov)
19.^Sairam K, Rao CV, Babu MD, Goel RKProphylactic and curative effects of Bacopa monniera in gastric ulcer modelsPhytomedicine.(2001 Nov)
21.^Dorababu M, Prabha T, Priyambada S, Agrawal VK, Aryya NC, Goel RKEffect of Bacopa monniera and Azadirachta indica on gastric ulceration and healing in experimental NIDDM ratsIndian J Exp Biol.(2004 Apr)
25.^Saraf MK, Prabhakar S, Khanduja KL, Anand ABacopa monniera Attenuates Scopolamine-Induced Impairment of Spatial Memory in MiceEvid Based Complement Alternat Med.(2011)
29.^Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker JChronic effects of Brahmi (Bacopa monnieri) on human memoryNeuropsychopharmacology.(2002 Aug)
30.^Stough C, Lloyd J, Clarke J, Downey LA, Hutchison CW, Rodgers T, Nathan PJThe chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjectsPsychopharmacology (Berl).(2001 Aug)
32.^Stough C, Downey LA, Lloyd J, Silber B, Redman S, Hutchison C, Wesnes K, Nathan PJExamining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trialPhytother Res.(2008 Dec)
33.^Raghav S, Singh H, Dalal PK, Srivastava JS, Asthana OPRandomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairmentIndian J Psychiatry.(2006 Oct)
34.^Katz M, Levine AA, Kol-Degani H, Kav-Venaki LA compound herbal preparation (CHP) in the treatment of children with ADHD: a randomized controlled trialJ Atten Disord.(2010 Nov)
35.^Nathan PJ, Tanner S, Lloyd J, Harrison B, Curran L, Oliver C, Stough CEffects of a combined extract of Ginkgo biloba and Bacopa monniera on cognitive function in healthy humansHum Psychopharmacol.(2004 Mar)
36.^Maher BF, Stough C, Shelmerdine A, Wesnes K, Nathan PJThe acute effects of combined administration of Ginkgo biloba and Bacopa monniera on cognitive function in humansHum Psychopharmacol.(2002 Apr)
37.^Nathan PJ, Clarke J, Lloyd J, Hutchison CW, Downey L, Stough CThe acute effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy normal subjectsHum Psychopharmacol.(2001 Jun)
38.^Pase MP, Kean J, Sarris J, Neale C, Scholey AB, Stough CThe cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trialsJ Altern Complement Med.(2012 Jul)
41.^Prabhakar S, Saraf MK, Pandhi P, Anand ABacopa monniera exerts antiamnesic effect on diazepam-induced anterograde amnesia in micePsychopharmacology (Berl).(2008 Sep)
43.^Sathyanarayanan V, Thomas T, Einöther SJ, Dobriyal R, Joshi MK, Krishnamachari SBrahmi for the better? New findings challenging cognition and anti-anxiety effects of Brahmi (Bacopa monniera) in healthy adultsPsychopharmacology (Berl).(2013 Jan 26)
45.^Shinomol GK, Mythri RB, Srinivas Bharath MM, MuralidharaBacopa monnieri extract offsets rotenone-induced cytotoxicity in dopaminergic cells and oxidative impairments in mice brainCell Mol Neurobiol.(2012 Apr)
46.^Sheikh N, Ahmad A, Siripurapu KB, Kuchibhotla VK, Singh S, Palit GEffect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in ratsJ Ethnopharmacol.(2007 May 22)
50.^Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan KCognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer's disease modelJ Ethnopharmacol.(2010 Jan 8)
51.^Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan KNeuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical cultureJ Ethnopharmacol.(2008 Oct 30)
55.^Mathew J, Paul J, Nandhu MS, Paulose CSBacopa monnieri and Bacoside-A for ameliorating epilepsy associated behavioral deficitsFitoterapia.(2010 Jul)
56.^Shanmugasundaram ER, Akbar GK, Shanmugasundaram KRBrahmighritham, an Ayurvedic herbal formula for the control of epilepsyJ Ethnopharmacol.(1991 Jul)
59.^Mathew J, Balakrishnan S, Antony S, Abraham PM, Paulose CDecreased GABA receptor in the cerebral cortex of epileptic rats: effect of Bacopa monnieri and Bacoside-AJ Biomed Sci.(2012 Feb 24)
61.^Prince HK, Conn PJ, Blackstone CD, Huganir RL, Levey AIDown-regulation of AMPA receptor subunit GluR2 in amygdaloid kindlingJ Neurochem.(1995 Jan)
62.^Kral T, Erdmann E, Sochivko D, Clusmann H, Schramm J, Dietrich DDown-regulation of mGluR8 in pilocarpine epileptic ratsSynapse.(2003 Mar 15)
65.^Rai D, Bhatia G, Palit G, Pal R, Singh S, Singh HKAdaptogenic effect of Bacopa monniera (Brahmi)Pharmacol Biochem Behav.(2003 Jul)
67.^Downey LA, Kean J, Nemeh F, Lau A, Poll A, Gregory R, Murray M, Rourke J, Patak B, Pase MP, Zangara A, Lomas J, Scholey A, Stough CAn Acute, Double-Blind, Placebo-Controlled Crossover Study of 320 mg and 640 mg Doses of a Special Extract of Bacopa monnieri (CDRI 08) on Sustained Cognitive PerformancePhytother Res.(2012 Dec 19)
68.^Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal SAntioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampusPhytother Res.(2000 May)
70.^Sumathi T, Shobana C, Christinal J, Anusha CProtective Effect of Bacopa monniera on Methyl Mercury-Induced Oxidative Stress in Cerebellum of RatsCell Mol Neurobiol.(2012 Feb 26)
71.^Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GPBacopa monniera Linn. as an antioxidant: mechanism of actionIndian J Exp Biol.(1996 Jun)
75.^Rastogi M, Ojha RP, Devi BP, Aggarwal A, Agrawal A, Dubey GPAmelioration of age associated neuroinflammation on long term bacosides treatmentNeurochem Res.(2012 Apr)
77.^Dhanasekaran M, Tharakan B, Holcomb LA, Hitt AR, Young KA, Manyam BVNeuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monnieraPhytother Res.(2007 Oct)
78.^Zhou Y, Shen YH, Zhang C, Su J, Liu RH, Zhang WDTriterpene saponins from Bacopa monnieri and their antidepressant effects in two mice modelsJ Nat Prod.(2007 Apr)
80.^Kamkaew N, Norman Scholfield C, Ingkaninan K, Taepavarapruk N, Chootip KBacopa monnieri Increases Cerebral Blood Flow in Rat Independent of Blood PressurePhytother Res.(2012 Mar 23)
81.^Kamkaew N, Scholfield CN, Ingkaninan K, Maneesai P, Parkington HC, Tare M, Chootip KBacopa monnieri and its constituents is hypotensive in anaesthetized rats and vasodilator in various artery typesJ Ethnopharmacol.(2011 Sep 1)
84.^Vollala VR, Upadhya S, Nayak SLearning and memory-enhancing effect of Bacopa monniera in neonatal ratsBratisl Lek Listy.(2011)
85.^Singh A, Singh SKEvaluation of antifertility potential of Brahmi in male mouseContraception.(2009 Jan)
88.^Velmurugan K, Alam J, McCord JM, Pugazhenthi SSynergistic induction of heme oxygenase-1 by the components of the antioxidant supplement ProtandimFree Radic Biol Med.(2009 Feb 1)
90.^Kapoor R, Srivastava S, Kakkar PBacopa monnieri modulates antioxidant responses in brain and kidney of diabetic ratsEnviron Toxicol Pharmacol.(2009 Jan)